Aptose Bioscns (APTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
Operating Expenses | 6,346 | 5,600 | 6,325 | 5,611 | 10,329 |
Operating Income | -6,346 | -5,600 | -6,325 | -5,611 | -10,329 |
Other Income | 128 | 94 | 64 | 80 | 67 |
Pre-tax Income | -6,218 | -5,506 | -6,261 | -5,531 | -10,262 |
Net Income Continuous | -6,218 | -5,506 | -6,261 | -5,531 | -10,262 |
Net Income | $-6,218 | $-5,506 | $-6,261 | $-5,531 | $-10,262 |
EPS Basic Total Ops | -1.95 | -2.10 | -2.55 | -2.40 | -4.50 |
EPS Basic Continuous Ops | -2.01 | -2.07 | -2.51 | -2.40 | -4.53 |
EPS Diluted Total Ops | -1.95 | -2.10 | -2.55 | -2.40 | -4.50 |
EPS Diluted Continuous Ops | -2.01 | -2.07 | -2.51 | -2.40 | -4.53 |
EBITDA(a) | $-6,186 | $-5,447 | $-6,302 | $-5,582 | $-10,310 |